Home | Business News | Browse by Publication | P | Pharma Marketletter

Gilead 1st-qtr 2004 revenues rocket 87%.

Publication: Pharma Marketletter
Publication Date: 03-MAY-04
Format: Online
Delivery: Immediate Online Access
Full Article Title: Gilead 1st-qtr 2004 revenues rocket 87%.(Brief Article)

Article Excerpt
USA-based Gilead saw its revenues shoot up 87% to $309 million for the first quarter of 2004, driven by a "superb" performance from its lead drug Viread (tenofovir disoproxil fumarate), the company said.

Net income for the quarter reached $114 million, or $0.50 per share, from a net loss...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Fluoroquinolone use set to increase, says Datamonitor.(Brief Article), May 03, 2004
Latvia: 5%VAT on medicines from May 1.(Brief Article), May 03, 2004
Latvia: still too many pharmacies for EU.(Brief Article), May 03, 2004
AstraZeneca bolsters R&D with new facility.(Brief Article), May 03, 2004
Tokyo pharma stocks - week to April 26., May 03, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.